Table 3.

NaPB treatment reduces fasting glucose levels ^a.

Parameter	NaPB	Placebo	P value
Glucose, mmol/L b
day 0	8.7 ± 0.5	8.5 ± 0.5	0.53
day 15	7.7 ± 0.4	8.2 ± 0.5	0.06
Δ day 0-day 15	−1.0 ± 0.2	−0.3 ± 0.3	0.09
Insulin, mU/L	10.9 ± 1.2	11.1 ± 1.4	0.78
Triglycerides, mmol/L	1.9 ± 0.2	1.8 ± 0.2	0.50
Free fatty acids, µmol//L	614 ± 42	632 ± 50	0.51

^an = 16. Data expressed as mean ± SE. The intervention effect was analyzed using the paired student t-test. *P values < 0.05 NaPB vs. Placebo. Fasting blood samples were taken after 2 weeks (15 days) of NaPB treatment or placebo after an overnight fast. NaPB sodium phenylbutyrate, BCAA branched-chain amino acids.

^bn = 15.